ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.

$8.99  +0.15 (1.70%)
As of 12/03/2021 15:59:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  12/08/2020
Outstanding shares:  684,789,169
Average volume:  804,733
Market cap:   $6,053,536,254
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G76279101
Valuation   (See tab for details)
PE ratio:   -18.86
PB ratio:   3.02
PS ratio:   102.41
Return on equity:   -16.00%
Net income %:   -1,414.89%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy